Menopause age, reproductive span and hormone therapy duration predict the volume of medial temporal lobe brain structures in postmenopausal women.


Journal

Psychoneuroendocrinology
ISSN: 1873-3360
Titre abrégé: Psychoneuroendocrinology
Pays: England
ID NLM: 7612148

Informations de publication

Date de publication:
12 2023
Historique:
received: 18 01 2023
revised: 16 09 2023
accepted: 16 09 2023
medline: 10 11 2023
pubmed: 30 9 2023
entrez: 29 9 2023
Statut: ppublish

Résumé

Medial temporal lobe (MTL) atrophy is correlated with risk and severity of Alzheimer disease (AD) pathology and cognitive decline. Increasing evidence suggest that oestrogens affect the aging of MTL structures. Here we investigate the relationship between reproductive hormone exposure, polygenic scores for AD risk and oestradiol concentration, MTL anatomy and cognitive performance in postmenopausal women. To this end, we used data from 10,924 female participants in the UK Biobank from whom brain MRI and genetic data were available. We fitted linear regression models to test whether the volume of structures comprising the MTL were predicted by a) timing related to menopause, b) the use and timing of hormone replacement therapy (HRT) and c) polygenic scores for AD risk and oestradiol concentration. Results showed that longer use of HRT was associated with larger parahippocampal volumes (2.53 mm

Identifiants

pubmed: 37774659
pii: S0306-4530(23)00371-2
doi: 10.1016/j.psyneuen.2023.106393
pii:
doi:

Substances chimiques

Estrogens 0
Estradiol 4TI98Z838E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106393

Subventions

Organisme : Wellcome Trust
ID : WT200804
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT224267
Pays : United Kingdom

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no conflicting interests.

Auteurs

Jessica J Steventon (JJ)

Neuroscience and Mental Health Research Institute, Cardiff University, UK.

Thomas M Lancaster (TM)

Department of Psychology, University of Bath, UK.

Emily Simmonds Baker (ES)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Matthew Bracher-Smith (M)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Valentina Escott-Price (V)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Katherine S Ruth (KS)

University of Exeter Medical School, RILD Level 3 Royal Devon & Exeter Hospital, Barrack Road, Exeter EX2 5DW, UK.

William Davies (W)

Neuroscience and Mental Health Research Institute, Cardiff University, UK; MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Xavier Caseras (X)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK. Electronic address: CaserasX@cardiff.ac.uk.

Kevin Murphy (K)

Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, UK; School of Physics and Astronomy, Cardiff University, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH